MSLN and neoplasm: In the context of HGSC, Banville and colleagues conducted an investigation to identify antigens that could be targeted via combinatorial CAR-T platforms by investigating the simultaneous expression of FRα, mesothelin, and CA125 in different HGSC tumor samples (103).